Nico Aelmans (Group CEO) is pleased to announce that in order to cater for growth Research and Medical Chemicals Group (RMC) of which Buchem BV is an integral part has reinforced the management structure by following nominations as per 1st February 2022.

Johan Leugs will assume the responsibility of Chief Operating Officer

Luc Amkreutz has been appointed Chief Financial Officer

Casper (John) Frijns will support the group as Chief Marketing and Sales Officer

With these appointments RMC will be able to further drive the integration of Buchem’s sister companies Reseachem GmbH and Swant AG as well as preparing the ground for further acquisitions.

Buchem, the innovative Apeldoorn-based chemical concern, has supplied the current Mars mission with special thin sheets made from its TENAX adsorption material. The use of these sheets in the space in which sample tubes are cached ensures that the samples are given optimum protection from contamination by volatile organic substances which might penetrate or be released during the mission.

At this two-day event, you will experience a variety of presentations from top-ranked scientists on the wide-ranging applications of stable isotopes. These include MS and NMR facilitated research in environmental analysis, metabolism, metabolomics, proteomics, protein structure determination, RNA/DNA studies, and more!

At this two-day event, you will experience a variety of presentations from top-ranked scientists on the wide-ranging applications of stable isotopes. These include MS and NMR facilitated research in environmental analysis, metabolism, metabolomics, proteomics, protein structure determination, RNA/DNA studies, and more!